I don’t think trial results are going to have substantial lasting effects on share price. The market knows this works.
What bgt needs are clear steps towards commercialisation. Especially given patent expires in 2022.
Ann: Positive Results for Flavocide in Initial Field Testing, page-36
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.859M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17584 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.12pm 26/11/2024 (20 minute delay) ? |
| BGT (ASX) Chart |
Day chart unavailable
